1. Home
  2. Live Updates
  3. Ipelines

Live Breaking News & Updates on Ipelines

Stay informed with the latest breaking news from Ipelines on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Ipelines and stay connected to the pulse of your community

Purolite innovates biopharma with jetted resin

In a recent interview, Hayley Crowe, head of Ecolab's global life sciences business, shed light on Purolite's latest developments and its significant contributions to the biopharmaceutical industry.

United-kingdom , Praesto-jetting , Bio-developments , Pstream-processing , Arkets-amp-regulations , Ipelines , Merging-markets , Eparation-amp-purification , Etted-resin , Urolite , Anufacturing

University of Dundee spin-out bags £4m to develop active biologic drugs

UK-based biotech Glen Clova Scientific has raised £4 million in seed financing to develop a pipeline of a new generation of active biologic drugs.

United-kingdom , Glen-clova , Angus , Scotland , Moray-martin , Steven-powell , John-foerster , Patricia-reynolds , Doug-quinn , University-of-dundee , Norcliffe-capital , Glen-clova-scientific

AstraZeneca's Lynparza to remain dominant in PARP inhibitors market

Back in 2014, AstraZeneca and Merck were the first to receive FDA approval for their PARP inhibitor Lynparza (olaparib) for use in breast cancer gene (BRCA)-mutated metastatic ovarian cancer patients.

Johnson-zytiga , Biswajit-podder , Astrazeneca , Markets-amp-regulations , Ipelines , Merging-markets , Strazeneca , Arp-inhibitor , Ncology , Linical-trials ,

Segrist: The LNG Pause and a Big, Dumb Question

In trying to understand the White House’s decision to pause LNG export permits and wondering if it’s just a red herring, one big, dumb question must be asked.

White-house , District-of-columbia , United-states , New-york , Environmental-protection-agency , El-paso , Texas , New-mexico , Department-of-energy , Dubai , Dubayy , United-arab-emirates

SK pharmteco to manufacture Ferring Pharmaceuticals' gene therapy

SK pharmteco has signed an agreement with Ferring Pharmaceuticals, to scale up commercial manufacturing capacity for the drug substance of Ferring’s intravesical gene therapy Adstiladrin.

New-jersey , United-states , Finland , Parsippany , Bipin-dalmia , Joerg-ahlgrimm , Drug-administration , Ferring-pharmaceuticals , World-bladder-cancer-patient-coalition , Bacillus-calmette-gu , Markets-amp-regulations , Ipelines

Selkirk Pharma: Adapting to regulatory shifts and market demand

Ahead of CPHI North America, we caught up with Lisa Stiles, director, business development at Selkirk Pharma, an exhibitor at the event, to find out how the CMO is navigating regulatory changes, challenges and more.

Supply-chain , Digital-transformation-plan , Markets-amp-regulations , Io-developments , Iopharma-culture , Ipelines , Merging-markets , Mo , Ontract-manufacturing , Anufacturing , Upply-chain

SynOx Therapeutics secures $75m to fund tenosynovial giant cell tumor trial

SynOx Therapeutics has raised $75m in Series B financing, co-led by Forbion, HealthCap and new investor Bioqube Ventures.

Carlo-incerti , Jon-edwards , Ray-barlow , Synox-therapeutics , Ton-logtenberg , Markets-amp-regulations , Io-developments , Ipelines , Merging-markets , Umor , Linical-trial

Torbay Pharma: 'We are all about making sterile supply simple'

Torbay Pharmaceuticals is a sterile injectable contract manufacturer and licence holder based in Devon, UK. We spoke with CEO Emma Rooth about the company's heritage and how it is striving to support the U.S. market.

United-states , America , European-medicines-agency-in-europe , European-medicines-agency , Good-manufacturing-practices , Markets-amp-regulations , Ipelines , Merging-markets , Terile-injectables , Ontract-manufacturing , Harmacology

Eli Lilly under pressure: Can it solve GLP-1 supply squeeze?

Specific doses of Eli Lilly’s GLP-1 blockbuster drugs Mounjaro and Zepbound are currently facing a supply shortage, and frustrated patients are urging the pharma giant to act – fast.

Canada , India , Vietnam , Republic-of , David-ricks , Eli-lilly , Vikram-shanbhag , Nicolas-schmitz , Lilly-mounjaro , Lars-fruergaard , Novo-nordisk-wegovy , Novo-nordisk

Selkirk's rises to manufacturing biologics challenges with expansion

In the fast-paced domain of pharmaceutical contract development and manufacturing organizations (CDMOs), Selkirk Pharma believes it stands out as a beacon of innovation and reliability.

John-bertagnolli , Selkirk-pharma , Bio-developments , Ownstream-processing , Arkets-amp-regulations , Ipelines , Ntibody-drug-conjugates , Anufacturing , Dmo , Acility , Upply-chain